GONELLA JACQUES 4
4 · ANTARES PHARMA, INC. · Filed Aug 15, 2018
Insider Transaction Report
Form 4
GONELLA JACQUES
Director10% Owner
Transactions
- Sale
Common Stock
2018-08-13$3.09/sh−49,507$152,977→ 9,985,848 total
Footnotes (1)
- [F1]The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established in connection with estate planning.